ABC 60mg / 3TC 30mg / DTG 5mg, disp. tab.


Valid Article

Article is intended to be used with children (<12 years) ONLY. - Fixed-dose combinations of antiretroviral medicines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

See Related

Add article to list


Add Kit To Wishlist



Full Name

Paediatric abacavir/ lamivudine/ dolutegravir (pALD) fixed-dose combination

Therapeutic Action

Paediatric fixed-dose combination of three antiretrovirals (pALD):


HIV infection, according to dosage recommended by WHO.

First-line ART regimen for children at least 3 months of age and weighing 6 to 24.9 kg.

Instructions for use

Paediatric use only.

Tablets should be dispersed in water only and given orally once per day.

The fixed combination ABC 60 mg / 3TC 30 mg / DTG 5 mg replaces separate components ABC 120 mg / 3TC 60 mg + DTG 10 mg in children from 6 to < 25 kg.

Separate components ABC 120 mg / 3TC 60 mg + DTG 10 mg will still be used for children from 3 to 5.9 kg.


  • Below 25ºC - Protect from humidity
  • Keep the bottle tightly closed. Do not remove the desiccant.